Morpholino

MO1-adgrl3.1

ID

ZDB-MRPHLNO-130110-3

Name

MO1-adgrl3.1

Previous Names

None

Target

adgrl3.1 (1)

Sequence

5' - ATGTGAGTGTATCTCTGTACCTGAA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-adgrl3.1

Expressed Gene	Anatomy	Figures
slc6a3	caudal tuberculum dopaminergic neuron	Fig. S7 from Lange et al., 2012

Phenotype

Phenotype resulting from MO1-adgrl3.1

Phenotype	Fish	Figures
caudal tuberculum dopaminergic neuron decreased amount, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 3 from Lange et al., 2012
caudal tuberculum dopaminergic neuron mislocalised, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 3 from Lange et al., 2012
caudal tuberculum neuron disorganized, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 3 from Lange et al., 2012
locomotion decreased occurrence, abnormal	WT + MO1-adgrl3.1	Fig. 2 from Lange et al., 2018
locomotion increased occurrence, abnormal	AB/EKW + MO1-adgrl3.1	Fig. S6 from Lange et al., 2012
locomotion increased speed, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 2 from Lange et al., 2012
locomotory behavior increased process quality, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 1, Fig. S6 from Lange et al., 2012
swimming behavior process quality, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 2 from Lange et al., 2012
whole organism increased behavioural activity, abnormal	AB/EKW + MO1-adgrl3.1	Fig. 1 from Lange et al., 2012

Phenotype of all Fish created by or utilizing MO1-adgrl3.1

Phenotype	Fish	Conditions	Figures
locomotory behavior increased occurrence, abnormal	AB + MO1-adgrl3.1	chemical treatment by environment: paracetamol	Fig. S2 from Reuter et al., 2016
swimming behavior increased occurrence, abnormal	AB + MO1-adgrl3.1	chemical treatment by environment: paracetamol	Fig. S2 from Reuter et al., 2016
swimming behavior process quality, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 2 from Lange et al., 2012
caudal tuberculum dopaminergic neuron mislocalised, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 3 from Lange et al., 2012
locomotion increased speed, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 2 from Lange et al., 2012
whole organism increased behavioural activity, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 1 from Lange et al., 2012
locomotion increased occurrence, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. S6 from Lange et al., 2012
caudal tuberculum dopaminergic neuron decreased amount, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 3 from Lange et al., 2012
caudal tuberculum neuron disorganized, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 3 from Lange et al., 2012
locomotory behavior increased process quality, abnormal	AB/EKW + MO1-adgrl3.1	standard conditions	Fig. 1, Fig. S6 from Lange et al., 2012
locomotion decreased occurrence, abnormal	WT + MO1-adgrl3.1	chemical treatment by environment: eticlopride(1+)	Fig. 3 from Lange et al., 2018
locomotion occurrence, ameliorated	WT + MO1-adgrl3.1	chemical treatment by environment: quinpirole	Fig. 2 from Lange et al., 2018
locomotion increased occurrence, exacerbated	WT + MO1-adgrl3.1	chemical treatment by environment: haloperidol	Fig. 3 from Lange et al., 2018
locomotion increased occurrence, abnormal	WT + MO1-adgrl3.1	chemical treatment by environment: SKF 38393	Fig. 2 from Lange et al., 2018
locomotion decreased occurrence, abnormal	WT + MO1-adgrl3.1	standard conditions	Fig. 2 from Lange et al., 2018
locomotion decreased occurrence, abnormal	WT + MO1-adgrl3.1	chemical treatment by environment: SCH 23390	Fig. 3 from Lange et al., 2018
locomotion occurrence, ameliorated	WT + MO1-adgrl3.1	chemical treatment by environment: apomorphine	Fig. 2 from Lange et al., 2018

Citations